Pacira Biosciences Inc
NASDAQ:PCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
F
|
Fresenius Medical Care AG
SWB:FME
|
DE |
|
V
|
Valneva SE
LSE:0OB3
|
FR |
|
Factset Research Systems Inc
NYSE:FDS
|
US |
|
O
|
Occidental Petroleum Corp
SWB:OPC
|
US |
|
Ajinomoto Co Inc
TSE:2802
|
JP |
|
F
|
Flowers Foods Inc
XBER:FWF
|
US |
|
Toronto-Dominion Bank
TSX:TD
|
CA |
|
A
|
Altai Resources Inc
XTSX:ATI
|
CA |
|
C
|
Cigna Corp
F:CGN
|
US |
|
Comer Industries SpA
MIL:COM
|
IT |
|
Valneva SE
F:AYJ
|
FR |
|
A
|
Alexandria Real Estate Equities Inc
LSE:0HCH
|
US |
|
G
|
Goldman Sachs Group Inc
SWB:GOS
|
US |
|
P
|
Pioneer Natural Resources Co
XBER:PNK
|
US |
|
T
|
Toyota Motor Corp
DUS:TOM
|
JP |
|
Kingfisher PLC
LSE:KGF
|
UK |
|
10X Genomics Inc
LSE:0A88
|
US |
|
D
|
Dental Corporation PCL
SET:D
|
TH |
Wall St Price Targets
PCRX Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for PCRX is 30.26 USD with a low forecast of 23.23 USD and a high forecast of 39.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCRX's stock price target?
Price Target
30.26
USD
According to Wall Street analysts, the average 1-year price target for PCRX is 30.26 USD with a low forecast of 23.23 USD and a high forecast of 39.9 USD.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 6%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
50%
The compound annual growth rate for Operating Income over the next 5 years is 50%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
64%
The compound annual growth rate for Net Income over the next 7 years is 64%.
